Members of the FGF family play diverse roles in patterning, cell proliferation and differentiation during embryogenesis. To begin to address their function during craniofacial development we have analyzed the expression of 18 members of the Fgf family and the four members of the FGF-receptor family in the prospective midfacial region between E9.5 and E11.5 by whole-mount in situ hybridization. We show that at E9.5, Fgf3, -8, -9, -10 and -17 are broadly expressed in midfacial ectoderm. Concomitant with the outgrowth of the nasal processes at E10.5, expression of Fgf3, -8, -9, -10, -15, -17 and -18 was detected in spatially restricted regions of ectoderm at the edge of the nasal pit and at the oral edge of the medial nasal process. Expression of Fgf8, Fgf9, Fgf10 and Fgf17 was still observed in these domains at E11.5. In contrast to the restricted expression patterns of the ligands, FgfR1 and FgfR2 were broadly expressed in facial mesenchyme and ectoderm, respectively, indicating a wide competence of midfacial tissue to respond to FGF signaling. q
Results
The vertebrate face develops from buds of tissue that grow out and partially fuse to lay down the basic pattern of the adult face. Members of the FGF family have been implicated as key factors in controlling outgrowth and patterning of the developing limbs. As a ®rst step to investigate whether FGFs may have similar functions during midfacial development we have analyzed the expression of members of the FGF family between E9.5 and E11.5 of mouse development.
At E9.5, prior to outgrowth of the nasal processes, Fgf3, -8, -9, and -17 are broadly expressed in overlapping domains in the ectoderm covering the midfacial region (Fig.  1A ,E,I,M,Q). Fgf8 and -9 expression extends into the ectoderm dorsal from the nasal placodes (Fig. 1E,I , arrowheads) whereas Fgf10 transcripts are only detected in ectoderm dorso-laterally from the placodes (Fig. 1M, arrowhead) .
By E10.5, the mesenchyme surrounding the nasal placodes has grown out to form the medial and lateral nasal processes that¯ank the nasal pits. At this stage, Fgf8, -9 and -10 are expressed at high levels in overlapping domains around the nasal pits (Fig. 1F ,J,N) whereas Fgf3, -15 and -17 expression is restricted to ectoderm at the medial side of the nasal pits (Fig. 1B,V,R) . In addition, a stripe of Fgf8, -9, -17 and -18 expression is also detected along the oral edge of the medial nasal process (Fig. 1F ,J,R,X, arrows). Transverse vibratome sections through the stained embryos show that expression of all Fgfs at E10.5 is restricted to the ectoderm ( At E11.5, Fgf8, -9, and -10 expression is still detected around the nasal pit (Fig. 1H ,L,P) whereas Fgf17 expression is found only on its medial side (Fig. 1T ). In addition a continuous domain of Fgf8 and-9 expression on the oral side of the maxillary primordia and the medial nasal processes is now detected (Fig. 1H ,L arrows). Fgf17 expression remains restricted to the oral side of the medial nasal processes (Fig. 1T, arrow) . Expression of Fgf3 and -18 is no longer detected in the nasal region at E11.5. We were unable to detect speci®c expression of Fgf1, -2, -4, -5, -6, -7, -11, -12, -13, -14 and -21 in the midfacial region by whole-mount in situ hybridization between E9.5 and E11.5 (data not shown). Using the same probes, expression in other regions of the developing embryos was detected as previously reported.
Since the role of FGF signaling depends on distinct patterns of both ligands and receptors we also examined the expression of the four known FGF receptors using probes that recognize all splice variants. As shown in Fig.  2A ,D, FgfR1 and -2 are broadly and uniformly expressed in the midfacial region at E9.5. At E10.5 and E11.5, FgfR1 and FgfR2 are still widely expressed in the facial area (Fig.  2B,C,E,F) . Expression levels of FgfR1, however, are higher in the lateral nasal process and at the oral edge of the medial Fig. 1 . Gene expression of members of the Fgf family in the developing mouse face between E9.5 and E11.5 as detected by whole-mount in situ hybridization. The dashed line in the schematic drawing of an E10.5 mouse face in (D) indicates the plane of section of the transverse vibratome sections shown in (C,G,K,O,S,W,Y). Asterisks mark expression in the underlying forebrain. Arrowheads and arrows label expression in speci®c regions as described in the text. lnp, lateral nasal process; mn, mandibulary arch; mnp, medial nasal process; mx, maxillary process; np, nasal placode; oe, olfactory epithelium. nasal process than in the rest of the face (Fig. 2B , arrowheads). Sectioning of the stained embryos revealed that FgfR1 and -2 transcripts are predominantly localized in the mesenchyme and ectoderm, respectively (data not shown). We were unable to detect expression of FgfR3 and -4 in the midfacial region by whole-mount in situ hybridization (data not shown). The same probes did, however, show speci®c expression patterns in other regions of the embryo.
Our results show that multiple members of the FGF family are expressed in overlapping domains during development of the nasal and midfacial region and may therefore serve partially redundant functions. The broad expression of FgfR1 and FgfR2 indicates a wide competence of midfacial tissue to respond to FGF signaling.
Methods
Whole-mount RNA in situ hybridization was performed as previously described (Neubu Èser et al., 1997) . Antisense riboprobes were prepared from plasmids described in the references or generated by cloning the RT-PCR fragments speci®ed below (nucleotide numbering refers to the GenBank entries indicated) into pCRII-TOPO (Invitrogen): Fgf1, Fgf4, Fgf5: (Hebert et al., 1990) ; Fgf2: nt 87±465, accession number NM_008006; Fgf3: (Mansour and Martin, 1988) ; Fgf6: nt 15±616, accession numbers X51552, X51553, X51554; Fgf7: nt 139±366, accession number NM_008008; Fgf8: (Crossley and Martin, 1995) ; Fgf9: (Colvin et al., 1999) ; Fgf10: (Bellusci et al., 1997) ; Fgf11: nt 9±645, accession number NM-010198; Fgf12: nt 13±750, accession number AF020738; Fgf13: nt 10±735, accession number AF020737; Fgf14: nt 13±725, accession number NM_010201; Fgf15: (McWhirter et al., 1997) ; Fgf 17: (Maruoka et al., 1998) ; Fgf18: nt 22±592, accession number NM_008005; Fgf21: (Nishimura et al., 2000) ; FgfR1: (Yamaguchi et al., 1992) ; FgfR2: (Peters et al., 1992) ; FgfR3: (Peters et al., 1993) ; FgfR4: (Stark et al., 1991) .
For vibratome sectioning stained embryos were embedded into gelatin/albumin and cut on a Leica VT 1000S vibratome at 10±50 mm. Fig. 2 . Gene expression of FGFR1 and -2 in the developing mouse face between E9.5 and E11.5 as detected by whole-mount in situ hybridization. Arrowheads label expression in speci®c regions as described in the text. np, nasal placode; mn, mandibulary arch.
